Consistent with the in vitro data, we show that in AD, ALS, and MS, and in marmoset EAE, TSPO protein expression does not increase in CNS myeloid cells that express a pro-inflammatory phenotype, while expression is markedly increased in activated myeloid cells in all mouse models of these diseases. Here, TSPO is linked to Alzheimer disease.